Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Translational Oncology|October 7, 2018
Phenotypic and Expressional Heterogeneity in the Invasive Glioma CellsArtem Fayzullin, Cecilie J Sandberg, Matthew Spreadbury, et al.Neuro-Oncology Practice|November 29, 2023
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based studyEduardo Erasmo Mendoza Mireles, Erlend Skaga, Andres Server, et al.Neuropathology and Applied Neurobiology|May 24, 2024
Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencingSkarphedinn Halldorsson, Richard Mark Nagymihaly, Areeba Patel, et al.Neurosurgery|December 6, 2008
A comparison between stem cells from the adult human brain and from brain tumorsMercy Varghese, Havard Olstorn, Cecilie Sandberg, et al.Oncotarget|August 22, 2015
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cellsBiljana Stangeland, Awais A Mughal, Zanina Grieg, et al.Cancers|December 23, 2023
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional SamplingMarit Brynjulvsen, Elise Solli, Maria Walewska, et al.Journal of Magnetic Resonance Imaging : JMRI|January 6, 2021
Robustness of MR Elastography in the Healthy Brain: Repeatability, Reliability, and Effect of Different Reconstruction MethodsSiri F Svensson, José De Arcos, Omar Isam Darwish, et al.Clinical and Translational Medicine|January 1, 2020
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatmentErlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, et al.Molecular Cancer|August 22, 2015
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cellsAwais A Mughal, Zanina Grieg, Håvard Skjellegrind, et al.Journal of Proteome Research|April 10, 2019
Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem CellsIngvild Comfort Hvinden, Henriette Engen Berg, Daniel Sachse, et al.Pageof 4